Claudio Daniel
Navo Nájera
Investigador en el periodo 2012-2018
![Foto de Claudio Daniel](/img/uploaded/FF887500D4228BD707D939A66FFA2766.jpg)
![Foto de AstraZeneca (United Kingdom)](/img/noimage_org.png)
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (2)
2022
-
Controlled masking and targeted release of redox-cycling ortho-quinones via a C–C bond-cleaving 1,6-elimination
Nature Chemistry, Vol. 14, Núm. 7, pp. 754-765
-
Single Mutation on Trastuzumab Modulates the Stability of Antibody-Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry
Journal of the American Chemical Society, Vol. 144, Núm. 12, pp. 5284-5294